David R.W. Jayne's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 18,641 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 21 Nov 2024 | 18,641 | 18,641 | - | - | Director Stock Option (right to buy) | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 21 Nov 2024 | 12,135 | 56,499 (0%) | 0% | 0 | Common Shares | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 21 May 2024 | 4,946 | 44,364 (0%) | 0% | 5.7 | 28,390 | Common Stock | |
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2023 | 15,234 | 15,234 | - | - | Stock Option (right to buy) | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2023 | 9,310 | 58,043 (0%) | 0% | 0 | Common Stock | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2023 | 8,733 | 48,733 (0%) | 0% | - | Common Stock | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2023 | 8,733 | 49,310 (0%) | 0% | 11.3 | 98,334 | Common Stock | |
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2023 | 8,733 | 0 | - | - | Restricted Stock Units | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2022 | 10,000 | 40,000 (0%) | 0% | 3.6 | 36,200 | Common Stock | |
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 18 May 2022 | 10,000 | 0 | - | - | Stock Option (right to buy) | ||
| Aurinia Pharmaceuticals Inc | David R.W. Jayne | Director | 14 Jun 2021 | 31,347 | 31,347 | - | - | Stock Option (right to buy) |